Our story

2009

First organoid generated from mouse intestine

2011

First human organoid developed from intestinal epithelium

2013

Hubrecht Organoid Technology Foundation was established to upscale and commercialize organoid technology

2015

First cystic fibrosis patient treated based on organoid data

2017

HIT-CF validation trial launched

2018

First oncology clinical candidate entirely developed using organoid screening approved for clinical trials

2022

Expansion of lab facilities

2023

Hubrecht Organoid Technology becomes HUB Organoids B.V.

Leadership

HUB Organoids is led by a proficient team that has extensive expertise in scientific, commercial, and technological areas within the life sciences field. Their diverse backgrounds and skillset collectively embody our company’s values, culture, and commitment to advancing patient-relevant therapeutic solutions to the world.